TY - JOUR
T1 - Point-counterpoint
T2 - A nucleic acid amplification test for Streptococcus pyogenes should replace antigen detection and culture for detection of bacterial pharyngitis
AU - Pritt, Bobbi S.
AU - Patel, Robin
AU - Kirn, Thomas J.
AU - Thomson, Richard B.
N1 - Funding Information:
R.P. reports grants from BioFire, Check-Points, Curetis, 3M, Merck, Hutchison Biofilm Medical Solutions, Accelerate Diagnostics, Allergan, and The Medicines Company. R.P. is a consultant to Curetis, Roche, Qvella, and Diaxonhit; monies are paid to the Mayo Clinic. In addition, R.P. has a patent on a Bordetella pertussis/B. parapertussis PCR assay issued, a patent on a device/method for sonication, with royalties paid by Samsung to the Mayo Clinic, and a patent on an antibiofilm substance issued. R.P. serves on an Actelion data monitoring board, receives travel reimbursement and an editor's stipend from ASM and IDSA, and receives honoraria from the USMLE, Up-to-Date, and the Infectious Diseases Board Review Course. R.B.T. has received consulting and speaker honoraria from BD Kiestra, research support from Nanosphere, and travel support from the Clinical and Laboratory Standards Institute, the American Society for Microbiology, and the College of American Pathologists.
Publisher Copyright:
Copyright © 2016, American Society for Microbiology. All Rights Reserved.
PY - 2016/10
Y1 - 2016/10
N2 - Nucleic acid amplification tests (NAATs) have frequently been the standard diagnostic approach when specific infectious agents are sought in a clinic specimen. They can be applied for specific agents such as S. pyogenes, or commercial multiplex NAATs for detection of a variety of pathogens in gastrointestinal, bloodstream, and respiratory infections may be used. NAATs are both rapid and sensitive. For many years, S. pyogenes testing algorithms used a rapid and specific group A streptococcal antigen test to screen throat specimens, followed, in some clinical settings, by a throat culture for S. pyogenes to increase the sensitivity of its detection. Now S. pyogenes NAATs are being used with increasing frequency. Given their accuracy, rapidity, and ease of use, should they replace antigen detection and culture for the detection of bacterial pharyngitis? Bobbi Pritt and Robin Patel of the Mayo Clinic, where S. pyogenes NAATs have been used for well over a decade with great success, will explain the advantages of this approach, while Richard (Tom) Thomson and Tom Kirn of the NorthShore University HealthSystem will discuss their concerns about this approach to diagnosing bacterial pharyngitis.
AB - Nucleic acid amplification tests (NAATs) have frequently been the standard diagnostic approach when specific infectious agents are sought in a clinic specimen. They can be applied for specific agents such as S. pyogenes, or commercial multiplex NAATs for detection of a variety of pathogens in gastrointestinal, bloodstream, and respiratory infections may be used. NAATs are both rapid and sensitive. For many years, S. pyogenes testing algorithms used a rapid and specific group A streptococcal antigen test to screen throat specimens, followed, in some clinical settings, by a throat culture for S. pyogenes to increase the sensitivity of its detection. Now S. pyogenes NAATs are being used with increasing frequency. Given their accuracy, rapidity, and ease of use, should they replace antigen detection and culture for the detection of bacterial pharyngitis? Bobbi Pritt and Robin Patel of the Mayo Clinic, where S. pyogenes NAATs have been used for well over a decade with great success, will explain the advantages of this approach, while Richard (Tom) Thomson and Tom Kirn of the NorthShore University HealthSystem will discuss their concerns about this approach to diagnosing bacterial pharyngitis.
UR - http://www.scopus.com/inward/record.url?scp=84991231677&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84991231677&partnerID=8YFLogxK
U2 - 10.1128/JCM.01472-16
DO - 10.1128/JCM.01472-16
M3 - Article
C2 - 27440817
AN - SCOPUS:84991231677
SN - 0095-1137
VL - 54
SP - 2413
EP - 2419
JO - Journal of clinical microbiology
JF - Journal of clinical microbiology
IS - 10
ER -